Fusion Antibodies are currently recruiting for a scientific position. Apply today at jobs@fusionantibodies.com Fusion Antibodies are currently recruiting for a scientific position. Please see more details below or email jobs@fusionantibodies.com Scientist – Antibody Biology About the Job Background This is a graduate level entry position at Fusion Antibodies Ltd. Fusion Antibodies is a CRO that […]
Monoclonal antibodies, or mAbs, have become a crucial tool and are used for both diagnostic and medical applications. This article will explain the importance of mAbs and antibody humanization techniques involved. If you are interested in Antibody Humanization services, check out our main service page here. The technology of monoclonal antibodies was pioneered by César Milstein and Georges […]
We would like to take this opportunity to wish you all a Merry Christmas and a Happy New Year! Dear Fusion Antibodies Clients, It has been a fantastic year for Fusion Antibodies with our humanization service in particular welcoming a large number of new clients (and some returning!). With 18+ Humanization projects completed this year and over […]
Fusion Antibodies are happy to announce we will be attending BIO-Europe which is to be held from the 2nd to the 4th of November 2015. BIO-Europe is the largest partnering conference in Europe and attracts thousands of companies and attendees from the biotech, pharma and finance industries. This year’s event will be held in Munich, […]
Fusion Antibodies are pleased to announce that we will be attending the 2015 Human Antibodies and Hybridomas Conference, to be held 28-30th of October at the University of Lausanne, Switzerland. Conference activities will include keynote lectures, presentations and contributed papers. The event will bring together top scientists from universities, bioscience companies and research institutes across […]
Fusion Antibodies Ltd, an antibody drug and cell line development CRO focused on the treatment of serious disease, has signed an exclusive licensing agreement with Clarity Pharmaceuticals Ltd. (Sydney, Australia) to further develop Fusion’s Cathepsin S specific antibody for the treatment of a range of cancers. Cathepsin S (CatS), is an enzyme which is expressed […]
